Cocaine Metabolite, Urine, Quantitative
Also known as: CDCO COCA
Use
This test is used for obtaining quantitative results of cocaine metabolites in urine, specifically Benzoylecgonine, to follow up a presumptive result. It is not intended for general screening purposes. The test is useful for verifying suspected drug use and monitoring treatment compliance in clinical settings.
Special Instructions
Not provided.
Limitations
This test is intended for medical purposes only and is not valid for forensic use. A result will be reported as positive only if the concentration value meets or exceeds the 50 ng/mL cutoff. The test has been developed and characterized by ARUP Laboratories but has not been cleared or approved by the FDA. The performance can be affected by improper specimen handling, specifically exposure to freeze/thaw cycles.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
Benzoylecgonine
Analyte
LOINC Codes
- 3394-4 - BZE Ur-mCnc
Result Turnaround Time
1-6 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
1 mL
Minimum Volume
0.5 mL
Container
ARUP standard transport tube
Collection Instructions
Collect random urine without additives or preservatives.
Storage Instructions
Store at room temperature.
Causes for Rejection
Specimens exposed to repeated freeze/thaw cycles.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 1 month |
| Frozen | 3 years |
Other tests from different labs that may be relevant